MDGL vs MIRM Stock Comparison
MDGL currently leads MIRM in this stock comparison, with AIQ scores of 57 vs 53. The clearest difference is quality, while MIRM has the stronger momentum profile.
What is the main difference between MDGL and MIRM?
MDGL leads the current stock comparison as Madrigal Pharmaceuticals, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Madrigal Pharmaceuticals, Inc. vs Mirum Pharmaceuticals, Inc.
MDGL leads
MDGL leads by 4 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 10 points over 30 sessions. Wall Street currently favors MIRM on target upside.
Fragile: 4 of 6 evidence groups support MDGL, its lead is narrowing, and its current signal state is conflicted.
Madrigal Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc.
The Algovestiq AIQ Score currently favors MDGL over MIRM, 57 versus 53 as of Nov 15, 2026. MDGL's advantage is driven primarily by stronger quality and risk resilience, while MIRM holds the stronger momentum profile. MDGL also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors MIRM. 4 of 6 covered evidence groups favor MDGL today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 4 points. MDGL lead: Weakening — the AIQ differential moved from 10 to 4 points over 30 sessions.
Compare Madrigal Pharmaceuticals, Inc. and Mirum Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare MDGL and MIRM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality67 vs 52MDGL +15
- Momentum40 vs 54MIRM +14
- Risk Resilience63 vs 51MDGL +12
- Value66 vs 57MDGL +9
4 of 6 evidence groups favor MDGL. MDGL’s edge is concentrated in quality and risk resilience; MIRM keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-5.0%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
Largest factor move: Momentum +2
No signal started or stopped since the prior session; its 4 active signals are unchanged.
MDGL's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — MDGL and MIRM both carry a full feed there.
The central trade-off
MDGL (Madrigal Pharmaceuticals, Inc.): the stronger current systematic profile, led by quality and risk resilience.
MIRM (Mirum Pharmaceuticals, Inc.): the counter-case, on momentum, technicals, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
MDGLMDGL on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
MDGLMDGL on combined revenue and EPS growth.
Value
MDGLMDGL on the peer-relative Value factor, by 9 points.
Momentum
MIRMMIRM on the Momentum factor, by 14 points.
Lower downside
MDGLMDGL on Risk Resilience, by 12 points.
Analyst upside
MIRMMIRM on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors MDGL, analyst targets favor MIRM. That disagreement is the most useful thing on this page.
| Measure | MDGL | MIRM | Note |
|---|---|---|---|
| Implied upside to target | +54.5% | +66.9% | MIRM has more room |
| Target dispersion | +30.6% | +45.9% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 19 | 14 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor MDGL. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | MDGL | 57 vs 53 |
| Fundamentals | MDGLon balance | revenue growth 18.4% vs 5.4%; EPS growth 195.5% vs 41.5%; TTM ROE 8.8% vs 75.2%; gross margin 91% vs 81.7%; operating margin -10.7% vs -25.3% — MDGL takes 4 of 5 decided legs, not all of them |
| Valuation | MDGL | Value 66 vs 57 |
| Technicals | MIRM | Price vs 50-day -10.2% vs 5.9%; vs 200-day -13.8% vs -4.5% |
| Risk Resilience | MDGL | Risk Resilience 63 vs 51 |
| Analyst expectations | MIRM | Target upside 54.5% vs 66.9% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of MDGL and MIRM and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 4 points. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on MDGL.
How the comparison changed
120 daily snapshots · May 27 – Nov 13MDGL lead: Weakening — the AIQ differential moved from 10 to 4 points over 30 sessions.
- Today
- MDGL +4
- 57 vs 53
- 7 sessions ago
- MDGL +7
- 57 vs 50
- 30 sessions ago
- MDGL +10
- 57 vs 47
- 90 sessions ago
- MDGL +7
- 60 vs 53
The lead changed hands 3 times in this window, most recently on Jul 31 when MDGL moved ahead of MIRM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 2 bearish / 2 neutral, conflicted
Only MDGL
- ADX Trend Weakening — neutral, trend, medium horizon
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-5.0%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
1 bullish / 2 bearish / 1 neutral, conflicted
Only MIRM
- Low Volume Rally Warning — bearish, volume, short horizon (0.54x)
- TRIX Bullish Signal — bullish, momentum, short horizon
Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.
MDGL leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.51%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +0.71%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1MIRM closes the Quality gap — currently 15 points behind, the largest single contributor to MDGL's edge.
- 2MIRM's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3MDGL's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
- 4The narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 4-point move would eliminate MDGL's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
MDGL leads on balance| Metric | MDGL | MIRM |
|---|---|---|
| Revenue growth (YoY) | 18.4% | 5.4% |
| EPS growth (YoY) | 195.5% | 41.5% |
| Gross margin | 91% | 81.7% |
| Operating margin | -10.7% | -25.3% |
| Return on equity (TTM) | 8.8% | 75.2% |
| Debt to equity | 0.56 | -13.72 |
Performance
MIRM leads 5 of 6 windows| Metric | MDGL | MIRM |
|---|---|---|
| 1 week (5 sessions) | 6.9% | 0.3% |
| 1 month (20 sessions) | -5% | 17.3% |
| 3 months (63 sessions) | -18.6% | -5.8% |
| 6 months (126 sessions) | -18.4% | -8% |
| Year to date | -26.6% | 19% |
| 1 year (252 sessions) | -19.2% | 32.8% |
Technicals
MIRM has the stronger structure| Metric | MDGL | MIRM |
|---|---|---|
| RSI (14) | 42.5 | 59.9 |
| ADX (14) | 24.8 | 26.1 |
| Price vs 50-day | -10.2% | 5.9% |
| Price vs 200-day | -13.8% | -4.5% |
| Volatility (1M, annualized) | 49.9% | 50.6% |
Risk
MDGL is the more resilient| Metric | MDGL | MIRM |
|---|---|---|
| Beta | 0.41 | 1.07 |
| Sharpe ratio | -0.32 | 0.79 |
| Sortino ratio | -0.46 | 1.12 |
| Max drawdown | -34.3% | -38.4% |
| Current drawdown | -29.1% | -26.9% |
| Annualized volatility | 42.6% | 48.6% |
| Value at risk (95%) | -4.1% | -4.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, MDGL or MIRM?
On the Algovestiq AIQ Score, MDGL is the stronger of the two as of Nov 15, 2026, scoring 57 against MIRM's 53. The edge comes from quality and risk resilience. MIRM is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is MDGL or MIRM the better buy right now?
MDGL carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 4 points. Treat the lead as provisional.
Why does the AIQ Score favor MDGL over MIRM?
The composite weights Quality, Value, Momentum and Risk Resilience. MDGL leads Quality by 15 points; MIRM leads Momentum by 14 points; MDGL leads Risk Resilience by 12 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, MDGL or MIRM?
Analyst price targets imply +54.5% upside for MDGL and +66.9% for MIRM, so the Street currently favors MIRM. That points the opposite way to the AIQ Score, which favors MDGL. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, MDGL or MIRM?
MDGL is the better-valued of the two on the peer-relative Value factor. MDGL on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, MDGL or MIRM?
MDGL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, MDGL or MIRM?
MIRM on the Momentum factor, by 14 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, MDGL or MIRM?
MDGL is the more resilient of the two, so the other name carries the higher downside risk. MDGL on Risk Resilience, by 12 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is MDGL more profitable than MIRM?
The profitability evidence is mixed: gross margin 91% vs 81.7%; operating margin -10.7% vs -25.3%; ttm roe 8.8% vs 75.2%. MDGL leads on two measures and MIRM on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is MDGL's lead over MIRM getting stronger or weaker?
MDGL lead: Weakening — the AIQ differential moved from 10 to 4 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-07-31, when MDGL moved ahead of MIRM.
What would change the MDGL vs MIRM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: MIRM closes the Quality gap — currently 15 points behind, the largest single contributor to MDGL's edge; MIRM's Death Cross Active resolves — a bearish trend rule currently active against it; MDGL's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 6 points over 30 sessions, and a further 4-point move would eliminate MDGL's advantage entirely.
What do the current signals say about MDGL and MIRM?
MDGL: 3 bullish / 2 bearish / 2 neutral, conflicted. MIRM: 1 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on MDGL is Death Cross Active (bearish, long horizon). On MIRM it is Death Cross Active (bearish, long horizon).
Compare MDGL and MIRM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.